Table 2.
Comparasion of total composite scores and subscores between TKA patients with and without kinesiophobia.
| Variable 1 | Low Kinesiophobia N (55) | High Kinesiophobia (20) | p-Value * | ||||
|---|---|---|---|---|---|---|---|
| Median | Q1 | Q3 | Median | Q1 | Q3 | ||
| POD1 | |||||||
| PCStotal 1 a | 1.59 | 1.10 | 2.52 | 2.76 | 2.33 | 3.71 | 0.002 |
| PCS 1 b | 2.6 | 1.40 | 4.00 | 4.7 | 3.35 | 5.55 | 0.002 |
| PITS1 c | 1 | 1.00 | 2.00 | 2.00 | 1.00 | 3.75 | 0.039 |
| PSE1 d | 0.50 | 0.00 | 2.00 | 1.12 | 0.00 | 2.75 | 0.180 |
| POD5 | |||||||
| PCStotal2 e | 0.31 | 0.09 | 0.55 | 1.28 | 0.59 | 2.15 | 0.000 |
| PCS2 f | 0.00 | 0.00 | 0.70 | 2.35 | 0.90 | 3.60 | 0.000 |
| PITS2 g | 0.43 | 0.14 | 0.43 | 1.57 | 1.00 | 2.14 | 0.000 |
| PSE2 h | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.50 | 0.166 |
1 = The values are given as numerical rating scale scores by a median with interquartile range (IQR); * Mann–Whitney U test; a: PCStotal 1 = composite score of patient-reported outcome measures on POD1; b: PCStotal 1 = the Pain Composite Score on POD1; c: PITS1 = the Pain Interference Total Score on POD1; d: PSE1 = the Pain Side Effects composite score on POD1; e: PCStotal2 = composite score of patient-reported outcome measures on POD5; f: PCS2 = the Pain Composite Score on POD5; g: PITS2 = the Pain Interference Total Score on POD5; h: PSE2 = the Pain Side Effects composite score on POD5.